NDC 0574-0611

PODOFILOX

Podofilox

PODOFILOX is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Padagis Us Llc. The primary component is Podofilox.

• Product ID: 0574-0611_a9e73e11-abbe-43a3-8ec4-48c9eca20329
• NDC: 0574-0611
• Product Type: Human Prescription Drug
• Proprietary Name: PODOFILOX
• Generic Name: Podofilox
• Dosage Form: Solution
• Route of Administration: TOPICAL
• Marketing Start Date: 2002-01-29
• Marketing Category: ANDA / ANDA
• Application Number: ANDA075600
• Labeler Name: Padagis US LLC
• Substance Name: PODOFILOX
• Active Ingredient Strength: 5 mg/mL
• Pharm Classes: Decreased Mitosis [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0574-0611-05

1 BOTTLE, GLASS in 1 CARTON (0574-0611-05) > 3.5 mL in 1 BOTTLE, GLASS

• Marketing Start Date: 2002-01-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0574-0611-05 [00574061105]

PODOFILOX SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA075600
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2002-01-29

Drug Details

Active Ingredients

Ingredient	Strength
PODOFILOX	5 mg/mL

OpenFDA Data

• SPL SET ID: 6af07697-5203-43e0-ba35-83683af851c3
• Manufacturer:
  • Paddock Laboratories, LLC
• UNII:
  • L36H50F353
• RxNorm Concept Unique ID - RxCUI:
  • 582926

Pharmacological Class

• Decreased Mitosis [PE]
• Decreased Mitosis [PE]

NDC Crossover Matching brand name "PODOFILOX" or generic name "Podofilox"

NDC	Brand Name	Generic Name
0574-0611	PODOFILOX	PODOFILOX
0591-3204	Podofilox	Podofilox
63629-8832	Podofilox	Podofilox
0023-6118	Condylox	podofilox